Sensei Biotherapeutics, Inc.
NASDAQ:SNSE
0.49 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 13.011 | 17.795 | 7.159 | 16.596 | 0.251 | 0.653 |
| Short Term Investments
| 52.746 | 89.321 | 140.462 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 65.757 | 17.795 | 147.621 | 16.596 | 0.251 | 0.653 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 1.493 | 0.344 | 0.374 | 3.48 | 0.251 | 0.123 |
| Total Current Assets
| 67.25 | 108.589 | 148.542 | 20.076 | 0.502 | 1.28 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 7.038 | 9.724 | 4.644 | 1.266 | 0.268 | 0.123 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.086 | 0.063 | 0.039 | 0.086 | 0.447 | 0.447 |
| Total Non-Current Assets
| 7.124 | 9.787 | 4.683 | 1.352 | 0.715 | 0.57 |
| Total Assets
| 74.374 | 118.375 | 153.225 | 21.428 | 1.217 | 1.85 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 1.694 | 4.473 | 2.456 | 3.882 | 3.451 | 1.108 |
| Short Term Debt
| 2.439 | 2.131 | 0.68 | 0.032 | 16.055 | 0.696 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | -4.473 | 0 | -0.032 | 2.083 | 0.652 |
| Other Current Liabilities
| 1.51 | 6.935 | 1.753 | 0.948 | 0.125 | 0.207 |
| Total Current Liabilities
| 5.643 | 9.066 | 4.889 | 4.83 | 21.714 | 2.663 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 3.769 | 5.902 | 1.674 | 0.567 | 0 | 4.05 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.067 | 0 | 0.149 | 72.474 | 48.165 | 48.617 |
| Total Non-Current Liabilities
| 3.836 | 5.902 | 1.823 | 73.041 | 48.165 | 52.667 |
| Total Liabilities
| 9.479 | 14.968 | 6.712 | 77.871 | 69.879 | 55.33 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 153.225 | 72.336 | 47.545 | 47.545 |
| Common Stock
| 0.003 | 0.003 | 0.003 | 0 | 0.002 | 0.002 |
| Retained Earnings
| -231.895 | -197.794 | -149.206 | -112.412 | -92.312 | -75.572 |
| Accumulated Other Comprehensive Income/Loss
| -0.209 | -1.004 | -0.333 | 0 | -0.002 | -0.314 |
| Other Total Stockholders Equity
| 296.996 | 302.202 | 142.824 | -16.367 | -23.895 | -25.141 |
| Total Shareholders Equity
| 64.895 | 103.407 | 146.513 | -56.443 | -68.662 | -53.48 |
| Total Equity
| 64.895 | 103.407 | 146.513 | -56.443 | -68.662 | -53.48 |
| Total Liabilities & Shareholders Equity
| 74.374 | 118.375 | 153.225 | 21.428 | 1.217 | 1.85 |